- The World Health Organization expects to decide whether to give emergency approval for China’s two main COVID-19 vaccines in the next two weeks.
- Simao said the WHO could decide on a vaccine made by Sinopharm by the end of this week, and one made by Sinovac Biotech by the end of next week.
- China has already deployed millions of doses of both vaccines at home and has exported them to many countries, particularly in Latin America, Asia and Africa.
A recent news article published in the Reuters reveals that WHO expects decision on two Chinese COVID-19 vaccines in next two weeks.
China exports vaccines
China has already deployed millions of doses of both vaccines at home and has exported them to many countries, particularly in Latin America, Asia and Africa.
An emergency listing from the WHO is an indication to national regulators of a shot’s safety and efficacy, and would allow the Chinese vaccines to be included in COVAX, the global programme to provide vaccines mainly for poor countries.
First vaccine from non-western country
If approved, the Chinese vaccines would be the first from a non-Western country to gain approval from the global health body.
So far the WHO has given emergency approval to vaccines from Pfizer-BioNTech, AstraZeneca and Johnson & Johnson.
It is also expected to review Moderna’s shot this week.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe
Source: Reuters
